Plus Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.16

-0.01 (-4.18%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +7,454.6% upside

Low Target $8.46

Average Target $11.77

High Target $14.40

Current Price $0.16

Current
$0.16

Target
$11.77

$8.46 $11.77 avg $14.40

Scenario Analysis

Bear Case

$8.46

5,330.0%

Low target

Base Case

$11.77

+7,454.6%

Avg target

Bull Case

$14.40

+9,142.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.77

-91.2% from high

52-Week Low

$0.16

+-4.7% from low

Target vs 52W High

$11.77

+565.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%